Pharmaceutical companies have welcomed the move, as such drugs eat away business competitiveness of compliant makers.
The drug administrator will recruit around 1,000 inspectors and superintendents in phases to enforce constant vigilance against adulteration and malpractices, a senior DGDA official said.
"The DGDA will recruit around 150 officials in the first phase to fill the district-level vacancies," Dr Zakia Begum, a deputy director of the DGDA, said yesterday.
The DGDA officials, equipped and supported by testing agencies, will frequently visit pharmaceutical plants and drug markets to check quality of products, Zakia said.
The government on January 17 gave more empowerment to the drug administrator by turning it into Directorate General of Drug Administration from Directorate of Drug Administration (DDA).
The under-stuffed DDA had to inspect around 300 pharmaceutical plants, issue drug licences, register imports of raw materials, and check product quality and prices at market level.
The DGDA has recently finalised its organogram and got a government go-ahead to recruit the officials and provide them with modern facilities.
Mahmud Hassan, business development officer of Eskayef Bangladesh Ltd, said local pharmaceutical businesses will now become more competitive.
"You can't sustain with reputation in a market, which is uneven for different players. If a company can do business providing substandard materials with inadequate monitoring, the reputation of the sector must be in trouble," Hassan said.
The expansion and modernisation of DGDF will help boost the sector and make it more competitive, he added.
MA Kalam, chairman of Chemico Laboratories Ltd, said the new steps of the drug administrator will help identify and eliminate the grey pharma market of the country.
jasim@thedailystar.net
From: M. M. Chowdhury (Mithu) <cgmpservices@yahoo.com>
To: cgmpservices@yahoo.com
Sent: Fri, March 5, 2010 2:55:18 PM
Subject: Calling BD Govt to implement strick GMP rules to drug manufactures to save lives
From: M. M. Chowdhury (Mithu) <cgmpservices@yahoo.com>
To: cgmpservices@yahoo.com
Cc: z.hussain@globalstrategyexchange.com
Sent: Fri, January 15, 2010 4:21:11 PM
Subject: [BDBusiness] Pharma Contract Manufacturing Seminar in Dhaka, Bangladesh: March 21-22, 2010
Contract Manufacturing Seminar for the Pharmaceuticals & Biotech Companies in Dhaka, Bangladesh: March 21-22, 2010
Contract Manufacturing for Pharmaceuticals & Biotech Companies:
In an ever turbulant economy pharmaceuticals and biotech companies are being influenced by the financial and operational benefits of outsourcing further aspects of their manufacturing process. As a result of this it is important for a company to mitigate risks while maximizing profit and production. At our contract manufacturing for pharmaceuticals and biotech conference, we have Gathered many high level industry experts to provide insights and unique solutions for the most common challenges faced in this industry. Our sessions and workshop will assist your organization to be ready to capture the market of CMO. By attending this conference, you will hear industry specific case studies and example addressing:
Analyzing the CMO market: Indispensable tools for choosing a preferred CMO.
Due diligence in the emerging markets.
Execution of multiple outsourcing projects.
Maximizing Innovation: Addressing the importance of small biotech's and start-ups
influencing the ability to sustain validation and process compliance - Post CMO collaboration.
Monitoring and ensuring the quality of outsourced manufactured packaging
And much more including over 4+ hours of sheduled netwoking, insightful interactive panel discussions and a series of interactive workshops.
Venue : Dhaka Sheraton Hotel
Dhaka, Bangladesh.
Date : 21-22 March; 2010.
Guest Speaker:
Mr. M M Chowdhury, CEO of Amreteck Pharma LLC, USA (www.amreteckpharma. com) is a guest speaker at the seminar and will cover few topics regarding Quality. We encourage you to register to this seminar to gain knowledge and prospect of the Pharma contract manufacturing business in Asia.
__._,_.___
